Gonadotroph tumours with a low SF‐1 labelling index are more likely to recur and are associated with enrichment of the PI3K‐AKT pathway

Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors

(2020) John Turchini et al.   ENDOCRINE PATHOLOGY

Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas

(2019) Florian Grimm et al.   ACTA NEUROCHIRURGICA

Pathology of pituitary neuroendocrine tumours: present status, modern diagnostic approach, controversies and future perspectives from a neuropathological and clinical standpoint

(2019) Emilija Manojlovic‐Gacic et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs

(2019) Yuxing Liao et al.   NUCLEIC ACIDS RESEARCH

Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification

(2019) Marie Buchy et al.   Pituitary

A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal

(2019) C. Villa et al.   VIRCHOWS ARCHIV

Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution

(2019) Sylvia L. Asa et al.   Pituitary

Epidemiology and biomarker profile of pituitary adenohypophysial tumors

(2018) Ozgur Mete et al.   MODERN PATHOLOGY

Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner

(2018) Femina Rauf et al.   ONCOGENE

A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal

(2018) Guido Rindi et al.   MODERN PATHOLOGY

GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors

(2018) Ozgur Mete et al.   MODERN PATHOLOGY

Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre

(2018) S Asioli et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal

(2017) S L Asa et al.   ENDOCRINE-RELATED CANCER

Gene expression profiling of fast- and slow-growing non-functioning gonadotroph pituitary adenomas

(2017) Camilla Maria Falch et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

What's new in pituitary pathology?

(2017) Sylvia L Asa et al.   HISTOPATHOLOGY

Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas

(2016) Ozgur Mete et al.   MODERN PATHOLOGY

The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible

(2016) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease

(2015) Jenifer P. Suntharalingham et al.   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas

(2015) Hiroshi Nishioka et al.   ENDOCRINE PATHOLOGY

Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications

(2015) Christian P. Miermeister et al.   Acta Neuropathologica Communications

Null Cell Adenomas of the Pituitary Gland: an Institutional Review of Their Clinical Imaging and Behavioral Characteristics

(2014) James A. Balogun et al.   ENDOCRINE PATHOLOGY

Silent Corticotroph Adenomas After Stereotactic Radiosurgery: A Case–Control Study

(2014) Zhiyuan Xu et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype

(2014) Cheng-Chia Lee et al.   Pituitary

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

(2013) Jacqueline Trouillas et al.   ACTA NEUROPATHOLOGICA

Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas

(2013) Misu Lee et al.   ACTA NEUROPATHOLOGICA

Inhibition of Sox2-dependent activation of Shh in the ventral diencephalon by Tbx3 is required for formation of the neurohypophysis

(2013) M.-O. Trowe et al.   DEVELOPMENT

Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates

(2012) Eleonora Duregon et al.   HUMAN PATHOLOGY

Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells

(2012) Clara V Alvarez et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Steroidogenic Factor-1 and Human Disease

(2012) Ranna El-Khairi et al.   SEMINARS IN REPRODUCTIVE MEDICINE

Expression and function of ErbB receptors and ligands in the pituitary

(2011) Odelia Cooper et al.   ENDOCRINE-RELATED CANCER

High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors

(2010) Silviu Sbiera et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Histologic and immunohistochemical study of clinically non-functioning pituitary adenomas

(2010) Toshiaki Sano et al.   PATHOLOGY INTERNATIONAL

KI-67 IN PITUITARY NEOPLASMS

(2009) Fateme Salehi et al.   NEUROSURGERY

The spatial and temporal expression of delta-like protein 1 in the rat pituitary gland during development

(2008) Takashi Nakakura et al.   HISTOCHEMISTRY AND CELL BIOLOGY

The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1

(2008) E. P. Sablin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA